MACQUARIE GROUP LTD - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$66,051,000
-0.9%
648,453
-1.8%
0.08%
+9.2%
Q2 2023$66,629,000
+7.6%
660,281
-1.9%
0.08%
+2.7%
Q1 2023$61,946,000
-0.5%
673,327
-1.9%
0.07%0.0%
Q4 2022$62,249,000
+2.3%
686,166
-14.3%
0.07%
-1.3%
Q3 2022$60,856,000
-12.0%
800,634
-2.1%
0.08%
-3.8%
Q2 2022$69,116,000
-5.8%
817,646
-2.2%
0.08%
+39.3%
Q1 2022$73,340,000
+4.0%
835,785
+3.6%
0.06%
-5.1%
Q4 2021$70,533,000
+10.7%
806,370
+3.5%
0.06%
+9.3%
Q3 2021$63,694,000
-11.0%
778,850
-0.7%
0.05%
-8.5%
Q2 2021$71,562,000
+16.7%
784,328
+9.4%
0.06%
-32.2%
Q1 2021$61,309,000
+7.1%
717,236
+18.3%
0.09%
+3.6%
Q4 2020$57,228,000
+4.4%
606,032
-3.9%
0.08%
-9.7%
Q3 2020$54,812,000
-5.7%
630,318
-5.3%
0.09%
-7.0%
Q2 2020$58,122,000
-15.6%
665,474
-20.3%
0.10%
-29.1%
Q1 2020$68,832,000
-16.3%
834,834
-3.9%
0.14%
+20.5%
Q4 2019$82,241,000
+8.0%
868,533
-0.9%
0.12%
-8.6%
Q3 2019$76,183,000
-69.1%
876,676
-67.6%
0.13%
-8.6%
Q2 2019$246,849,000
+181.9%
2,703,417
+196.8%
0.14%
-6.0%
Q1 2019$87,564,000
+10.4%
910,798
-1.4%
0.15%
-2.6%
Q4 2018$79,291,000
-1.3%
924,032
-0.9%
0.15%
+16.8%
Q3 2018$80,334,000
+10.0%
932,387
-3.6%
0.13%
+4.0%
Q2 2018$73,042,000
-7.5%
966,937
-1.0%
0.13%
-12.5%
Q1 2018$78,960,000
-18.2%
976,617
-15.1%
0.14%
-15.8%
Q4 2017$96,572,000
-3.4%
1,150,212
-1.2%
0.17%
-4.5%
Q3 2017$99,989,000
+2.4%
1,164,692
-0.5%
0.18%0.0%
Q2 2017$97,656,000
+31.9%
1,169,957
+17.4%
0.18%
+32.6%
Q1 2017$74,039,000
+3.7%
996,890
+1.7%
0.14%
-1.5%
Q4 2016$71,423,000
-37.6%
980,549
-32.4%
0.14%
-37.7%
Q3 2016$114,518,000
-53.6%
1,450,328
-51.5%
0.22%
-8.7%
Q2 2016$246,862,000
+136.4%
2,991,894
+107.6%
0.24%
+14.8%
Q1 2016$104,410,000
-12.8%
1,441,333
+3.6%
0.21%
-14.6%
Q4 2015$119,741,000
-21.7%
1,391,689
-16.4%
0.25%
-25.0%
Q3 2015$153,020,000
-5.5%
1,664,712
+1.1%
0.33%
+2.5%
Q2 2015$161,879,000
-12.2%
1,646,119
-12.0%
0.32%
-11.6%
Q1 2015$184,442,000
+4.9%
1,870,414
-1.5%
0.36%
-0.3%
Q4 2014$175,889,000
-8.4%
1,898,216
-7.0%
0.36%
-11.9%
Q3 2014$192,053,000
-3.1%
2,040,296
-6.8%
0.41%
-6.8%
Q2 2014$198,135,000
+13.9%
2,188,611
+7.0%
0.44%
+47.3%
Q1 2014$173,909,000
+9.0%
2,045,503
+3.0%
0.30%
+4.9%
Q4 2013$159,574,000
+9.5%
1,985,248
+4.5%
0.29%
+0.4%
Q3 2013$145,677,000
+7.5%
1,899,065
-0.9%
0.28%
-3.7%
Q2 2013$135,483,0001,916,0370.30%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders